Benchmark and data visualization of Swiss public listed companies in the Biotechnology Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Switzerland public listed companies in the Biotechnology industry: 11
Switzerland Biotechnology total companies market cap (USD): $10.98 Billion
Switzerland Analysis
Top Swiss Companies
1-year stock performance comparison (base-100 daily closing prices)
| Company | Market Cap (USD) | Country | Sector | Industry |
|---|---|---|---|---|
| CRISPR Therapeutics AG |
$5.12 B
(Jan. 1, 2026) |
Switzerland
|
Healthcare
|
Biotechnology
|
| BB Biotech AG | $2.12 B |
Switzerland
|
Healthcare
|
Biotechnology
|
| Kuros Biosciences AG | $1.37 B |
Switzerland
|
Healthcare
|
Biotechnology
|
| Idorsia Ltd | $598.0 M |
Switzerland
|
Healthcare
|
Biotechnology
|
| VectivBio Holding AG |
$474.9 M
(Jan. 1, 2023) |
Switzerland
|
Healthcare
|
Biotechnology
|
| ADC Therapeutics SA |
$436.0 M
(Jan. 1, 2026) |
Switzerland
|
Healthcare
|
Biotechnology
|
| AC Immune SA |
$338.0 M
(Jan. 1, 2026) |
Switzerland
|
Healthcare
|
Biotechnology
|
| Santhera Pharmaceuticals Holding AG | $197.2 M |
Switzerland
|
Healthcare
|
Biotechnology
|
| Xlife Sciences AG |
$181.1 M
(Jan. 1, 2026) |
Switzerland
|
Healthcare
|
Biotechnology
|
| Molecular Partners AG | $139.9 M |
Switzerland
|
Healthcare
|
Biotechnology
|